Identification of CPT1A as a Prognostic Biomarker and Potential Therapeutic Target for Kidney Renal Clear Cell Carcinoma and Establishment of a Risk Signature of CPT1A-Related Genes

Figure 7

GSEA analysis for CPT1A in KIRC. (a) Adipocytokine signaling pathway. (b) Citrate cycle/TCA cycle. (c) Complement and coagulation cascades. (d) Cytokine-cytokine receptor interaction. (e) ECM receptor interaction. (f) Glutathione metabolism. (g) Glycosaminoglycan biosynthesis chondroitin sulfate. (h) Oxidative phosphorylation. (i) P53 signaling pathway. (j) PPAR signaling pathway. (k) Proteasome. (l) Ribosome. (m) Systemic lupus erythematosus.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)

(m)